Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.

A functional metagenomic approach identified novel and diverse soil-derived DNAs encoding inhibitors to methicillin-resistant Staphylococcus aureus (MRSA). A metagenomic DNA soil library containing 19 200 recombinant Escherichia coli BAC clones with 100 Kb average insert size was screened for antibiotic activity. Twenty-seven clones inhibited MRSA, seven of which were found by LC-MS to possess modified chloramphenicol ( Cm) derivatives, including three new compounds whose structures were established as 1-acetyl-3-propanoylchloramphenicol, 1-acetyl-3-butanoylchloramphenicol, and 3-butanoyl-1-propanoylchloramphenicol. Cm was used as the selectable antibiotic for cloning, suggesting that heterologously expressed enzymes resulted in derivatization of Cm into new chemical entities with biological activity. An esterase was found to be responsible for the enzymatic regeneration of Cm, and the gene trfA responsible for plasmid copy induction was found to be responsible for inducing antibacterial activity in some clones. Six additional acylchloramphenicols were synthesized for structure and antibacterial activity relationship studies, with 1- p-nitrobenzoylchloramphenicol the most active against Mycobacterium intracellulare and Mycobacterium tuberculosis, with MICs of 12.5 and 50.0 μg/mL, respectively.

[1]  H. Molina,et al.  Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens , 2018, Nature Microbiology.

[2]  Yuemao Shen,et al.  Unusual acylation of chloramphenicol in Lysobacter enzymogenes, a biocontrol agent with intrinsic resistance to multiple antibiotics , 2017, BMC Biotechnology.

[3]  A. Staniszewska,et al.  New agents approved for treatment of acute staphylococcal skin infections , 2016, Archives of medical science : AMS.

[4]  G. Węgrzyn,et al.  The use of fosmid metagenomic libraries in preliminary screening for various biological activities , 2014, Microbial Cell Factories.

[5]  K. Węgrzyn,et al.  Sequence-specific interactions of Rep proteins with ssDNA in the AT-rich region of the plasmid replication origin , 2014, Nucleic acids research.

[6]  S. Brady,et al.  Antibacterial enzymes from the functional screening of metagenomic libraries hosted in Ralstonia metallidurans. , 2014, FEMS microbiology letters.

[7]  H. Bode,et al.  Initiation of the flexirubin biosynthesis in Chitinophaga pinensis , 2014, Microbial biotechnology.

[8]  Meizhong Luo,et al.  A BAC based physical map and genome survey of the rice false smut fungus Villosiclava virens , 2013, BMC Genomics.

[9]  W. Tao,et al.  Characterization of two metagenome-derived esterases that reactivate chloramphenicol by counteracting chloramphenicol acetyltransferase. , 2011, Journal of microbiology and biotechnology.

[10]  Mary E. Powers,et al.  Staphylococcus aureus biofilms , 2011, Virulence.

[11]  R. Wallace,,et al.  Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes , 2011 .

[12]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Brady,et al.  Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. , 2010, Current opinion in microbiology.

[14]  D. Ferreira,et al.  Intramolecular transacetylation in salvinorins D and E. , 2010, Journal of natural products.

[15]  Christopher T. Walsh,et al.  Antibiotics for Emerging Pathogens , 2009, Science.

[16]  Á. Soriano,et al.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Micek.  Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[19]  C. Sohaskey.  Enzymatic inactivation and reactivation of chloramphenicol by Mycobacterium tuberculosis and Mycobacterium bovis. , 2004, FEMS microbiology letters.

[20]  T. Nyström.  MicroReview: Growth versus maintenance: a trade‐off dictated by RNA polymerase availability and sigma factor competition? , 2004, Molecular microbiology.

[21]  W. Szybalski,et al.  Conditionally amplifiable BACs: switching from single-copy to high-copy vectors and genomic clones. , 2002, Genome research.

[22]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[23]  M. Borodovsky,et al.  Heuristic approach to deriving models for gene finding. , 1999, Nucleic acids research.

[24]  F. Fang,et al.  Broad-host-range properties of plasmid RK2: importance of overlapping genes encoding the plasmid replication initiation protein TrfA , 1991, Journal of bacteriology.

[25]  G. Carrea,et al.  Synthesis of ester derivatives of chloramphenicol by lipase-catalyzed transesterification in organic solvents , 1990 .

[26]  R. W. Davis,et al.  Targeted selection of recombinant clones through gene dosage effects. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Nakano,et al.  Corynecin (chloramphenicol analogs) fermentation studies: Selective production of Corynecin I by Corynebacterium hydrocarboclastus grown on acetate , 1977, Biotechnology and bioengineering.

[28]  H. Reichenbach,et al.  Untersuchungen an Stoffwechselprodukten von Mikroorganismen, XI: Flexirubin, ein neuartiges Pigment aus Flexibacter elegans , 1976 .

[29]  J. Plourde,et al.  Biotransformation of antibiotics. I. Acylation of chloramphenicol by spores of Streptomyces griseus isolated from the Egyptian soil . , 1976, The Journal of antibiotics.

[30]  A. Argoudelis,et al.  Microbial transformation of antibiotics. VI. Acylation of chloramphenicol by Streptomyces coelicolor. , 1971, The Journal of antibiotics.

[31]  M. Liles,et al.  Challenges and Opportunities in Discovery of Secondary Metabolites Using a Functional Metagenomic Approach , 2017 .

[32]  Arnold L. Demain,et al.  Manual of Industrial Microbiology and Biotechnology , 1986 .